Karyopharm and Menarini Group Enter into Exclusive License Agreement to Commercialize NEXPOVIO (selinexor) in Europe and Other Key Global Territories Read more
Ascletis Expands Ritonavir Oral Tablet Production and Announces Oral Direct-Acting Antiviral Pipeline Against SARS-CoV-2 Virus Read more
Merck and Ridgeback’s Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19 Read more
Advancing AI Drug Discovery in Clinical Trials at SMi’s 3rd Annual AI in Drug Discovery Conference Read more
Exploring the Impact of Machine Learning and Artificial Intelligence in Drug Development from Discovery to Healthcare Read more